Covid-19 Demographics from a Tertiary Care Center: Does It Depreciate Quality-of-Life?
- PMID: 32953634
- PMCID: PMC7491595
- DOI: 10.1007/s12070-020-02144-w
Covid-19 Demographics from a Tertiary Care Center: Does It Depreciate Quality-of-Life?
Abstract
Novel Coronavirus-disease-2019 (Covid-19) caused by the severe-acute-respiratory-syndrome coronavirus-2 (SARS-CoV-2) shows a rapid spread all over the world. It's still an ongoing pandemic with greater morbidity and mortality. In our study, we describe clinical features, and demographics of patients presenting to our tertiary care center with Covid-19 infection. Global burden was around 14 million Covid-19 positive cases with .5 million deaths and rising as per WHO update. A descriptive analytical cross-sectional study was carried out from June 1st to 30th, 2020 in a tertiary care center. Patients who tested positive by Reverse Transcriptase-Polymerase chain reaction were included in the study and clinical characteristics and outcome of the patients were analyzed along with impact on quality-of-life. Sample size was 250. Mean age was around 41 years, with age range from 15 to 75 years. Gender ratio was 1:2.4, with male preponderance. Most common presenting symptom was throat pain (60%). Rhinorrhea and sneezing complaints were not recorded. Clinical categorization was done and scored accordingly. Clinical outcomes of above patients showed complication rate 5.2%, mortality rate .8%, with discharge and recovery rate being rate 94.8% and 96% respectively. Fear of COVID-19 scale was used to assess quality-of-life impact. We found throat pain was the most common symptom in our study. No cases reported with rhinorrhea/sneezing. Good recovery rate noted. Quality-of-life impacted.
Keywords: Covid-19; DEMOGRAPHICS; Fear of COVID-19 scale; Outcomes; Quality-of-life; RT-PCR; SARS-CoV-2.
© Association of Otolaryngologists of India 2020.
Conflict of interest statement
Conflicts of interestThe authors declare that they have no conflict of interest.
Figures
Similar articles
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.J Assoc Physicians India. 2020 Jul;68(7):19-26. J Assoc Physicians India. 2020. PMID: 32602676
-
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.J Epidemiol Glob Health. 2020 Sep;10(3):214-221. doi: 10.2991/jegh.k.200806.002. J Epidemiol Glob Health. 2020. PMID: 32954712 Free PMC article.
-
Human and novel coronavirus infections in children: a review.Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25. Paediatr Int Child Health. 2021. PMID: 32584199 Review.
-
Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.J Transl Autoimmun. 2021;4:100083. doi: 10.1016/j.jtauto.2021.100083. Epub 2021 Jan 6. J Transl Autoimmun. 2021. PMID: 33521616 Free PMC article. Review.
Cited by
-
Prevalence of co-morbidities and its association with mortality in Indian patients with COVID-19: A meta-analysis.Indian J Anaesth. 2022 Jun;66(6):399-418. doi: 10.4103/ija.ija_845_21. Epub 2022 Jun 21. Indian J Anaesth. 2022. PMID: 35903589 Free PMC article.
-
Validation of the French Version of the Fear of COVID-19 Scale and Its Associations with Depression, Anxiety, and Differential Emotions.Int J Ment Health Addict. 2022;20(4):2057-2071. doi: 10.1007/s11469-021-00499-x. Epub 2021 Jul 23. Int J Ment Health Addict. 2022. PMID: 34335119 Free PMC article.
-
COVID-19 and Menstrual Status: Is Menopause an Independent Risk Factor for SARS Cov-2?J Midlife Health. 2020 Oct-Dec;11(4):240-249. doi: 10.4103/jmh.JMH_288_20. Epub 2021 Jan 21. J Midlife Health. 2020. PMID: 33767566 Free PMC article.
-
Ear, Nose, and Throat Practice Guidelines: An Update for COVID-19.Int Arch Otorhinolaryngol. 2021 Aug 4;25(4):e621-e627. doi: 10.1055/s-0041-1736424. eCollection 2021 Oct. Int Arch Otorhinolaryngol. 2021. PMID: 34777595 Free PMC article. Review.
-
Demographic profile and outcome of patients admitted to a COVID dedicated hospital in Bangladesh during the second wave.Medicine (Baltimore). 2021 Sep 17;100(37):e27281. doi: 10.1097/MD.0000000000027281. Medicine (Baltimore). 2021. PMID: 34664887 Free PMC article.
References
-
- Naming the coronavirus disease (COVID-19) and the virus that causes it [Internet]. Who.int. 2020 [cited 10 July 2020]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technica.... Accessed 10 July 2020
-
- WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. Covid19.who.int. 2020 [cited 17 July 2020]. https://covid19.who.int/?gclid=Cj0KCQjw3s_4BRDPARIsAJsyoLNhzR3vKusagdkNx.... Accessed 10 July 2020
-
- Who.int. 2020 [cited 27 July 2020]. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... Accessed 12 July 2020
-
- Aggarwal S, Garcia-Telles N, Aggarwal G, Lavie C, Lippi G, Henry BM. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): early report from the United States. Diagnosis. 2020;7(2):91–96. doi: 10.1515/dx-2020-0046. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous